NEW YORK, NY / ACCESSWIRE / September 30, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for potential violations of the federal securities laws. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting Click Here
LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Acadia Healthcare (ACHC) shares plunged after the operator of behavioral health facilities said it was being investigated by federal authorities looking into its "admissions, length of stay and billing practices."
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for potential violations of the federal securities laws. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting Click Here
LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Acadia Healthcare Co. Inc. plummeted Friday after the operator of behavioral-healthcare facilities disclosed that it was the subject of a government investigation into how patients were treated.
Acadia Healthcare Co has agreed to pay $19.85 million to settle allegations the company billed for medically unnecessary inpatient behavior health services, the U.S. Justice Department said on Thursday.
LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.